Raul Gainetdinov

From Wikipedia, the free encyclopedia
Raul Gainetdinov
Gainetdinov Raul.jpg
Born
Raul R. Gainetdinov

(1964-09-01) September 1, 1964 (age 57)
Known forTAAR
Dopamine receptors
Scientific career
FieldsNeuropsychopharmacology
Medicine
Biology
InstitutionsDuke University
Italian Institute of Technology
Saint Petersburg University
Academic advisors

Raul Gainetdinov (born September 1, 1964) is a pharmacologist and neuroscientist. The main direction of his research is psychiatric and neurological diseases of the brain like schizophrenia, ADHD, depression and Parkinson's disease. He is the author of fundamental scientific works in pharmacology of dopamine,[1] β-Arrestins[2][3] and NMDA receptors.[4] He is a pioneer researcher of Trace amine-associated receptors.[5][6][7]

Career[]

  • 1988-1996 PhD student - Senior Scientist, Institute of Pharmacology Russian Academy of Medical Sciences, Moscow, Russia.[8]
  • 1996-2008 Postdoctoral Researcher - Associate Research Professor, Department of Cell Biology, Duke University, North Carolina, USA.[9]
  • 2008-2016 Senior Researcher, Department of Neuroscience and Brain Technologies, Italian Institute of Technology, Genova, Italy.[9]
  • Since 2015 Director of Institute of Translational Biomedicine[9] and Head of Laboratory of Neuroscience and Molecular Pharmacology, Saint Petersburg State University, Saint Petersburg, Russia.[10]

Influence[]

Since 2018 Raul Gainetdinov has been included in the Web of Science Highly Cited Researchers list.[11][12] h-index 79.[13]

Since 2013 he has been the chairman of the nomenclature committee for dopamine receptors of International Union of Basic and Clinical Pharmacology (IUPHAR).[14]

Pictures[]

Gainetdinov Lefkowitz Caron
Back row: Raul Gainetdinov, Marc Caron,[15] Robert Lefkowitz
Front row: Laura Bohn,[16] Fang Lin[17]

References[]

  1. ^ Beaulieu JM, Gainetdinov RR (2011-03-01). "The Physiology, Signaling, and Pharmacology of Dopamine Receptors". Pharmacological Reviews. 63: 182–217. doi:10.1124/pr.110.002642. PMID 21303898. S2CID 2545878.
  2. ^ Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005-07-29). "An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior". Cell. 122 (2): 261–273. doi:10.1016/j.cell.2005.05.012. PMID 16051150.
  3. ^ Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT (1999-12-24). "Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2". Science. 286 (5449): 2495–2498. doi:10.1126/science.286.5449.2495. PMID 10617462.
  4. ^ Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999-08-20). "Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia". Cell. 98 (4): 427–436. doi:10.1016/S0092-8674(00)81972-8. PMID 10481908.
  5. ^ Premont RT, Gainetdinov RR, Caron MG (2001-08-14). "Following the trace of elusive amines". Proceedings of the National Academy of Sciences. 98 (17): 9474–9475. Bibcode:2001PNAS...98.9474P. doi:10.1073/pnas.181356198. PMC 55475. PMID 11504935.
  6. ^ Sotnikova TD, Caron MG, Gainetdinov RR (2009-04-23). "Trace Amine-Associated Receptors as Emerging Therapeutic Targets". Molecular Pharmacology. 76 (2): 229–235. doi:10.1124/mol.109.055970. PMC 2713119. PMID 19389919.
  7. ^ Gainetdinov RR, Hoener MC, Berry MD (2018-07-01). "Trace Amines and Their Receptors". Pharmacological Reviews. 70 (3): 549–620. doi:10.1124/pr.117.015305. PMID 29941461.
  8. ^ "Dr. Raul R Gainetdinov | Insight Medical Publishing". www.imedpub.com. Retrieved 2021-09-20.
  9. ^ a b c "Institute of Translational Biomedicine".{{cite web}}: CS1 maint: url-status (link)
  10. ^ "Laboratory of Neuroscience and Molecular Pharmacology".{{cite web}}: CS1 maint: url-status (link)
  11. ^ "Web of Science Highly Cited Researchers 2019". Web of Science.{{cite web}}: CS1 maint: url-status (link)
  12. ^ "Web of Science Highly Cited Researchers 2020". Web of Science.{{cite web}}: CS1 maint: url-status (link)
  13. ^ "Raul R. Gainetdinov".{{cite web}}: CS1 maint: url-status (link)
  14. ^ "IUPHAR subcommittee and family contributors".{{cite web}}: CS1 maint: url-status (link)
  15. ^ "Marc G. Caron".{{cite web}}: CS1 maint: url-status (link)
  16. ^ "Laura Bohn".{{cite web}}: CS1 maint: url-status (link)
  17. ^ "Fang-Tsyr Lin".{{cite web}}: CS1 maint: url-status (link)
Retrieved from ""